| References |
Top |
| REF 1 |
Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: a novel mechanism of gene regulation. J Biol Chem. 2005 Aug 5;280(31):28451-62.
|
| REF 2 |
p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res. 2002 Jan 1;62(1):141-51.
|
| REF 3 |
Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1. Biochem J. 2012 Mar 15;442(3):611-20.
|
| REF 4 |
Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell. 2010 Jun 15;17(6):535-46.
|
| REF 5 |
Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature. 1998 May 7;393(6680):88-91.
|
| REF 6 |
Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor. Mol Cell Proteomics. 2009 Oct;8(10):2212-26.
|
| REF 7 |
Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell. 2001 Feb 9;104(3):365-76.
|
| REF 8 |
Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program. J Biol Chem. 2008 Jan 11;283(2):1146-55.
|
| REF 9 |
Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. Mol Endocrinol. 2005 Oct;19(10):2451-65.
|
| REF 10 |
Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression. J Biol Chem. 2004 Jan 30;279(5):3509-15.
|
| REF 11 |
Coordinate regulation of estrogen receptor degradation by Mdm2 and CREB-binding protein in response to growth signals. Oncogene. 2013 Jan 3;32(1):117-26.
|
| REF 12 |
Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell. 2007 Apr 13;26(1):75-87.
|
| REF 13 |
Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells. 2001 Oct;6(10):857-68.
|
| REF 14 |
Transcriptional coactivators CBP and p300 cooperatively enhance HNF-1alpha-mediated expression of the albumin gene in hepatocytes. J Biochem. 2004 Sep;136(3):313-9.
|
| REF 15 |
K63-polyubiquitinated HAUSP deubiquitinates HIF-1 and dictates H3K56 acetylation promoting hypoxia-induced tumour progression. Nat Commun. 2016 Dec 9;7:13644.
|
| REF 16 |
The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res. 1996 Nov 1;24(21):4139-45.
|
| REF 17 |
Transactivation and growth suppression by the gut-enriched Krpel-like factor (Krpel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction. Nucleic Acids Res. 2000 Mar 1;28(5):1106-13.
|
| REF 18 |
Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells. Oncogene. 2012 Nov 22;31(47):4946-59.
|
| REF 19 |
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1074-9.
|
| REF 20 |
Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci. 2005 Dec;30(4):560-71.
|
| REF 21 |
Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. J Biol Chem. 2005 Sep 23;280(38):32569-77.
|
| REF 22 |
Regulation of the BRCA1 gene by an SRC3/53BP1 complex. BMC Biochem. 2011 Sep 13;12:50.
|
| REF 23 |
A human RNA polymerase II complex containing factors that modify chromatin structure. Mol Cell Biol. 1998 Sep;18(9):5355-63.
|
| REF 24 |
Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene. 2007 Jan 18;26(3):382-94.
|
| REF 25 |
Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription. Mol Cell. 2002 Feb;9(2):265-77.
|
| REF 26 |
Functional association between CBP and HNF4 in trans-activation. Biochem Biophys Res Commun. 1997 Dec 29;241(3):664-9.
|
| REF 27 |
A transcriptional switch mediated by cofactor methylation. Science. 2001 Dec 21;294(5551):2507-11.
|
| REF 28 |
Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation do... J Biol Chem. 2002 Nov 8;277(45):43168-74.
|
| REF 29 |
Characterization of human activating transcription factor 4, a transcriptional activator that interacts with multiple domains of cAMP-responsive element-binding protein (CREB)-binding protein. J Biol Chem. 1997 Sep 19;272(38):24088-95.
|
| REF 30 |
MTUS1 silencing promotes E-selectin production through p38 MAPK-dependent CREB ubiquitination in endothelial cells. J Mol Cell Cardiol. 2016 Dec;101:1-10.
|
| REF 31 |
FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005 Sep;2(3):153-63.
|
| REF 32 |
Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell. 1998 Mar;1(4):507-18.
|
| REF 33 |
A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol Cell Biol. 1998 Apr;18(4):2218-29.
|
| REF 34 |
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol. 2005 Aug;25(16):6964-79.
|
| REF 35 |
Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J Biol Chem. 2003 Jan 24;278(4):2370-6.
|
| REF 36 |
Physical and functional interaction between the transcriptional cofactor CBP and the KH domain protein Sam68. Mol Cancer Res. 2002 Nov;1(1):48-55.
|
| REF 37 |
Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol Cell. 1998 Oct;2(4):457-67.
|
| REF 38 |
p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Mol Cell Biol. 2005 Mar;25(6):2419-30.
|
| REF 39 |
SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev. 1996 Nov 15;10(22):2903-11.
|
